Home›Companies›Biotech & Pharma›Mel-Mont Medical

Mel-Mont Medical, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 17, 2025·Suggest an edit

About Mel-Mont Medical

Mel-Mont Medical is a private company based in Doral, Florida. It has reported $10,152,021 raised in three offerings on Form D since November 2020. Its chief executive is Frank Melendez.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 11, 2025Dec 17, 2025$250,000of $5.0M target3$83,333EquityRule 506(b)Form D ↗
Aug 25, 2023Sep 21, 2023amended Dec 16, 2025$6,902,021of $7.5M target69$100KEquityRule 506(b)Form D/A ↗1 earlier filing
Oct 30, 2020Nov 20, 2020$3,000,000fully sold1$3.0MEquityRule 506(b)Form D ↗
Total, three offerings$10,152,021

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Mel-Mont Medical's Form D filed Dec 17, 2025.

MT
Michael Torres
Executive officer
OP
Octavio Gonzalez Paredo
Executive officer and director
LM
Liliana Montes
Executive officer and director
FM
Frank Melendez
CEO and director

Sources

  1. SECMel-Mont Medical, Inc. Form D, filed Sep 21, 2023
  2. SECMel-Mont Medical, Inc. filing history